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Abstract
Background: Individuals of black African ethnicity tend to have less visceral adipose tissue (VAT) but more
subcutaneous-abdominal adipose tissue (SCAT) than white Caucasians. However, it is unclear whether such
distribution of abdominal fat is beneficial for metabolic disease risk in black individuals. Here we compared the
associations between these specific abdominal fat depots, insulin sensitivity and metabolic syndrome risk.
Methods: A cross-sectional analysis of 76 black South African young adults (36 men; 40 women) aged 18–19 years
participating in the Birth to Twenty Cohort Study had VAT and SCAT measured by MRI. The metabolic syndrome traits
(blood pressure, lipid profile, fasting glucose and insulin) were measured and the values were combined into a metabolic
syndrome risk score. Fasting glucose and insulin were used to derive the HOMA-index of insulin resistance (HOMA-IR).
Results: Compared to men, women had greater VAT (mean: 16.6 vs. 12.5 cm2) and SCAT (median 164.0 vs. 59.9 cm2).
In men, SCAT (r = 0.50) was more strongly correlated to the metabolic syndrome score (MetS) than was VAT (r = 0.23),
and was associated with both MetS (P = 0.001) and HOMA-IR (P = 0.001) after adjustment for VAT and total fat mass.
In women, both abdominal fat compartments showed comparable positive correlations with MetS (r = 0.26 to 0.31),
although these trends were weaker than in men.
Conclusions: In young black South African adults, SCAT appears to be more relevant than VAT to metabolic
syndrome traits.
Background
Obesity is a significant public health issue world-wide. In
many middle- and low-income countries, obesity co-exists
with under-nutrition and such ‘double burden’ of disease
risk presents a difficult challenge for health services [1]. In
South Africa, the prevalence of overweight or obesity is
high in adolescents (30 % of girls; 10 % of boys) and in
adults (69 % of women; 39 % of men) [2, 3].
The risk of obesity-related metabolic diseases may rise
with increasing abdominal adiposity, in particular visceral
(intra-abdominal) adiposity (VAT) [4, 5]. Many studies have
reported ethnic differences in the risks of obesity-related
metabolic diseases [6–8], which might be partly explained
by ethnic differences in the distribution of abdominal fat
[9–11]. There is good evidence that individuals of black
African origin have less VAT but more abdominal subcu-
taneous fat (abdominal SCAT) for the same degree of total
body fat than white individuals [10, 12–14]. Despite these
differences, black individuals are more hyperinsulinaemic
and may have higher risk of type 2 diabetes (T2D) than
white individuals [15, 16]. Therefore, abdominal SCAT may
actively contribute to the metabolic disturbances in black
individuals, in whom positive associations have been
reported with fasting and 2-h insulin levels [12, 17].
Abdominal SCAT has higher lipolytic activity than per-
ipheral SCAT (gluteal-femoral or appendicular SCAT)
and therefore releases substantially more free fatty
acids into the systemic circulation [18, 19]. High free
fatty acids levels are thought to increase peripheral in-
sulin resistance by reducing glucose uptake in skeletal
muscle [20, 21].
Abdominal SCAT is not homogeneous, but can be se-
parated into deep (D-SCAT) and superficial subcutaneous
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(S-SCAT) compartments, differentiated by location relative
to the fascia superficialis [22]. In animal models, D-SCAT
is metabolically more active than S-SCAT [14], and a ten-
dency to accumulate D-SCAT rather than S-SCAT could
potentially explain the high metabolic disease risk in black
individuals despite lower amounts of VAT. In some studies,
among Pima Indians [22], mixed ethnicity [9] or un-
defined ethnicity [23, 24], D-SCAT and VAT showed
similar strengths of association to metabolic syndrome
traits, such as insulin resistance. Comparison of the meta-
bolic correlates between different abdominal fat compart-
ments could help to understand their biological relevance.
In this study, we therefore examined whether total
body fat, VAT, abdominal SCAT or its sub-compartments
are related to metabolic syndrome traits in black South
African young adults. We hypothesised that SCAT as well
as VAT may have adverse metabolic consequences in this
population.
Methods
Study population
A computer generated random sample of 100 healthy
black South African young adults (48 men; 52 women)
aged 18–19 years old participating in the Birth to Twenty
cohort study (Bt20), were recruited to this study when they
attended their annual data collection visit at the Chris
Hani-Baragwanath Hospital, Soweto. Bt20 is a large-
scale longitudinal study of child and adolescent health
and development, which started in 1989 [25]. Exclusion
criteria for the current assessment included pregnancy.
Cross-sectional analyses were performed on the final
sample of 76 individuals (36 men; 40 women) who had
complete data on MRI and metabolic traits. Missing
data were due to technical issues and participant re-
fusals to undergo MRI scanning or venous sampling.
No significant differences were observed between indi-
viduals in the original study and those included in this
analysis with regard to anthropometry and body com-
position (data not shown). The Ethics Committee on
Human Subjects at the University of the Witwatersrand
approved the study. Written informed consent was ob-
tained from all study participants.
Anthropometric measures and blood pressure
Anthropometry included: weight measured in light cloth-
ing and barefoot to the nearest 0.1 kg using a digital scale
(Tanita model TBF-410; Arlinghton Heights; USA); height
measured barefoot to the nearest 0.1 cm using a wall
mounted stadiometer (Holtain, Crymych, UK); waist and
hip circumferences measured with a non-stretchable
fibreglass insertion tape at the level of the umbilicus and at
the largest gluteal diameter, respectively; and skinfold thick-
nesses measured with a Harpenden caliper at the biceps,
triceps, subcapsular, and suprailiac sites. Trained staff
performed all measurements. BMI was calculated as
Weight/Height2 in kg/m2.
Arterial blood pressure (BP) was measured in triplicate
at 5-min intervals with an automated blood pressure
monitor (Omron upper arm automated blood pressure
machine; the Netherlands) with the participant rested
and seated for at least 5 min. The first measurement was
discarded and the second and third were averaged.
Body composition
MRI
A whole body 1.5 T GE MRI scanner (GE Healthcare,
Piscataway, NJ, USA) was used to acquire 17 respiratory-
gated, T1-weighted, water-suppressed, turbo spin echo
transaxial images centred on the L4 vertebral level. The
slice thickness was 10 mm (2 mm gap between slices),
with an in-plane resolution of 0.94 × 0.94 mm, and a field
of view of 480 × 480 mm. Cross-sectional VAT and ab-
dominal SCAT areas were calculated from a single slice
located at the L4 vertebral body by a semi-automated
method, using an intensity thresholded map (Analyze 7.0,
BIR, Mayo Clinic, Rochester MN) with manual input to
differentiate between the abdominal fat compartments
(Additional file 1: Figure S1). In some cases where there
was artificial reduction in signal intensity due to arte-
facts in the MRI image, the threshold map was cor-
rected by using the autotrace facility within the Analyze
software. The same trained operator derived all of the
MRI parameters.
The proportion of total abdominal fat (VAT+SCAT) at-
tributable to VAT was also calculated as: VAT %= (VAT*100)/
(VAT+ abdominal SCAT). Abdominal SCAT was segregated
into D-SCAT and S-SCAT using the fascia superficialis
as the landmark. However, as abdominal SCAT showed
near co-linear relationships with both D-SCAT and S-
SCAT (r = 0.96-0.98) both in men and women, these sub-
compartments were not considered in further analyses.
Dual Energy X ray Absorptiometry (DEXA)
Total body fat mass (kg) was derived using DEXA fan-beam
technology (Hologic Discovery-W,) (Hologic, Bedford, MA,
USA, Hologic Discovery Software version 12.1). Before the
DEXA procedure was performed, the scanner was calibrated
according to standard protocol using a high-density poly-
ethylene phantom.
Biochemical parameters
Venous blood samples were collected following an over-
night fast. Plasma glucose was measured by an autoanalyzer
using standard enzymatic methods (Randox Laboratories;
South Africa) and insulin was measured by Immulite
(Siemens Chemiluminescent Technology). Blood lipids
(total cholesterol, high and low-density lipoprotein and tri-
glycerides) were measured by standard enzymatic methods
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(Randox Laboratories; South Africa). All assays were per-
formed in one central laboratory.
Metabolic risk factor score and HOMA-IR
The metabolic syndrome traits (systolic and diastolic BP,
lipid profile, fasting glucose and insulin) were combined
into a metabolic syndrome risk factor score (MetS), based
on International Diabetes Federation (IDF) criteria [26], but
excluding the waist circumference component as central
adiposity was considered here as the exposure. The follow-
ing continuously distributed variables were converted to
separate standardized scores: mean BP ([systolic BP + dia-
stolic BP]/2), fasting insulin, fasting glucose, inverted fasting
HDL-cholesterol, and fasting triglycerides. Standardization
of each factor was performed by subtracting the sample
mean from the individual mean and then dividing by the
sample SD. MetS was then calculated as the mean of
the five separate standardized scores [27]. Homeostasis
model assessment estimates of fasting insulin resistance
(HOMA-IR) were calculated as the product of fasting glu-
cose (mmol/L) and fasting insulin (μU/mL) divided by 22.5.
Statistical analyses
Statistical analyses were performed using Stata (version
12.0 StataCorp, College Station, Texas, USA). Descrip-
tive data are presented as mean ± SD, or median and
interquartile range. To examine whether the associations
between SCAT and HOMA-IR or MetS differed between
sexes, the interaction term (sex x SCAT) was added to
the regression models. There was significant sex inter-
action in the association between SCAT and HOMA-IR,
therefore all subsequent analyses were performed in men
and women separately. Variables with a skewed distribu-
tion were log-transformed. Pearson coefficients were used
first to describe inter-correlation between the various body
composition and abdominal fat parameters, and then to
describe the associations between these parameters and
MetS or HOMA-IR. Regression models were derived to
study the independent contributions of VAT and SCAT to
the metabolic syndrome traits. As DEXA total body fat
mass showed near co-linear relationships with SCAT
(r = 0.90-0.93) both in men and women, this covariate
was not considered in the final models.
Co-linearity between variables in the same model was
indicated by a variance inflation factor (VIF) > 5. To test
for possible non-linearity, we compared linear models to a
further model that included the quadratic term SCAT^2.
Results
Characteristics of the study population are summarised
in Table 1. The sample comprised of men and women
with a BMI range of 15.5–35.1 kg/m2 for men and
15.2–46.0 kg/m2 for women. Women had substantially
higher abdominal SCAT than men (median 164.0 vs.
59.9 cm2, Fig. 1) and also higher VAT (mean 16.6 vs.
12.5 cm2), and BMI (mean 23.6 vs. 21.1 kg/m2), fasting
insulin levels (median 11.6 vs. 6.5 μU/mL) and HOMA-IR
(median 2.5 vs 1.4), but lower systolic BP than men (114.6
vs 125.0 mmHg) and no difference in MetS.
Inter-correlations between body composition and
abdominal fat parameters (Table 2)
Correlations between VAT and abdominal SCAT were
moderately strong (men r = 0.72; women r = 0.63). Total
body fat mass (DEXA) was strongly correlated with ab-
dominal SCAT (men r = 0.90; women r = 0.93) and showed
moderately strong correlations with VAT (men r = 0.68;
women r = 0.66).
Associations with metabolic syndrome parameters
In men, abdominal SCAT was more strongly correlated
to MetS (r = 0.50; p = 0.002) and HOMA-IR (r = 0.66;
p < 0.0001) than were VAT (r = 0.23; p = 0.01 and r = 0.40;
p = 0.2, respectively), BMI (r = 0.45; p = 0.005 and r = 0.52;
p = 0.001) or total body fat mass (r = 0.37; p = 0.03 and
r = 0.58; p = 0.0002) (Table 3). In multivariate models,
in men abdominal SCAT was independently associated
with MetS (P = 0.004) and HOMA-IR (P < 0.001) after
adjustment for VAT (Table 4).
In women, abdominal SCAT (r = 0.28; p = 0.07) and VAT
(r = 0.26; p = 0.12) showed similar positive non-significant
trends with MetS (Table 3). Similar strength trends with
MetS were also seen in women for BMI (r = 0.31; p = 0.05)
and total body fat mass (r = 0.30; p = 0.06), however these
correlations were weaker than those seen in men. Multi-
variate models in women were unable to distinguish inde-
pendent associations between abdominal SCAT or VAT on
MetS and HOMA-IR (Table 4).
Correlations between the different body fat parame-
ters and individual metabolic traits are shown in the
Additional file 2: Table S1 and Additional file 3: Table S2.
In men, abdominal SCAT was more related to fasting in-
sulin and fasting glucose than other anthropometric/body
composition measures (Additional file 2: Table S1). In
women, abdominal SCAT and simple anthropometry were
associated with blood pressure (systolic and diastolic) only
(Additional file 3: Table S2).
Discussion
We observed, in young black South African men, that ab-
dominal SCAT was more strongly related to insulin resis-
tance and a combined metabolic syndrome risk factor score
than were other body fat parameters, including VAT;
furthermore, the metabolic relationships with abdom-
inal SCAT were independent of VAT. In women, SCAT
and VAT showed similar strength associations with
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metabolic syndrome risk factors, which were also simi-
lar in strength to DEXA and anthropometry measures.
Despite the lack of an apparent predominant effect of any
one body fat parameter on metabolic syndrome traits
within women, these women had on average nearly 3-fold
higher abdominal SCAT than men, which could explain
their higher levels of insulin resistance. The lack of associa-
tions with metabolic traits in women could possibly be due
to their limited range of SCAT, as only one woman had a
SCAT value below the median value for men (see Fig. 1).
Adverse consequences of abdominal SCAT could explain
why black individuals are not protected against insulin re-
sistance and T2D, despite relatively lower levels of VAT.
However, as we did not study their white counterparts,
it is still uncertain that this study demonstrates a differ-
ent phenomenon in whites and in blacks.
Table 1 Anthropometry, body fat distribution and metabolic risk factors in South African young adults
Men (n = 36) Women (n = 40) P-value*
Anthropometry
Weight (kg) 62.4 ± 10.9 60.6 ± 14.0 0.5
Height (cm) 172.0 ± 6.0 160.0 ± 5.0 <0.0001
BMI (kg/m2) 21.1 ± 3.6 23.6 ± 5.5 0.02
Waist circumference (cm) 74.8 ± 9.4 79.8 ± 11.6 0.04
Hip circumference (cm) 91.4 ± 12.0 100.3 ± 12.7 0.002
MRIa
VATb (cm2) 12.5 ± 9.0 16.6 ± 8.3 0.04
SCATc (cm2) 59.9 (35.9: 84.6) 164.0 (117.0; 266.9) 0.0001
VAT/(VAT + SCAT) (%) 15.0 (10.0; 20.0) 7.4 (5.7; 11.5) <0.0001
DXAd
Total fat (%) 12.7 (10.8; 15.0) 33.1 (26.4; 36.5) 0.0001
Total fat mass (kg) 7.0 (6.2; 9.5) 17.6 (14.0; 25.0) 0.0001
Metabolic variables
Total cholesterol (mmol/L) 3.6 (3.0; 4.0) 3.6 (3.2; 4.3) 0.7
LDL (mmol/L) 1.9 (1.4; 2.4) 2.0 (1.4; 2.4) 0.9
HDL (mmol/L) 1.3 (1.1;1.4) 1.3 (1.2; 1.5) 0.2
Triglycerides (mmol/L) 0.66 (0.51; 0.77) 0.63 (0.54; 0.76) 0.9
Fasting insulin μIU/mL 6.5 (4.1; 10.4) 11.6 (7.4; 12.9) 0.001
Fasting glucose (mmol/L) 5.2 (4.8; 5.5) 5.0 (4.7; 5.4) 0.5
Systolic BP (mmHg) 125.0 ± 10.1 114.6 ± 11.0 <0.0001
Diastolic BP (mmHg) 71.9 ± 7.5 70.5 ± 7.9 0.5
Metabolic traits
HOMA-IR 1.4 (0.9; 2.4) 2.5 (1.7;3.2) 0.002
Metabolic risk factor score −0.3 (−1.6; 1.5) 0.3 (−1.7; 1.5) 0.9
Data are means (±SD) or median (interquartile range)
*Sex differences by T-test or kruskal-wallis non parametric test
aMRI magnetic resonance imaging
bVAT visceral adipose tissue
cSCAT subcutaneous adipose tissue
dDual Energy x-ray absorptiometry
Fig. 1 Scatter plot of insulin resistance (HOMA-IR) against abdominal
subcutaneous adipose tissue area (MRI SCAT) in black South African
young men and women
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Previous studies have reported that abdominal SCAT
shows stronger correlations with insulin resistance than
does VAT: in middle-aged African American women [6],
in non-diabetic overweight middle-aged African American
women [28], and also in normal-weight African American
young girls aged 7–10 years [29]. Conversely, Barnerji et al.
reported that VAT but not SCAT was associated with insu-
lin sensitivity in older African American adults with type 2
diabetes (32 men and 20 women, aged 48–54 years) [30].
However, comparison to those studies may be limited as
they were conducted in different ages and different settings.
The relatively weaker associations that we observed in
women might reflect a threshold effect of abdominal SCAT
on metabolic risk.
Potential mechanisms have been suggested to explain
the higher T2D risk in individuals of black African origin
despite having less VAT [31]. Joffe et al. observed that
black South Africans with T2D had diminished β-cell
reserves leading to rapid exhaustion of insulin secretory
capacity [32]. Reduced insulin secretion capacity in black
Africans could arise due to genetic variants, for ex-
ample in the gene encoding insulin promoter factor-1,
a beta-cell specific transcription factor [13, 33–35], or
consequent to exposure to undernutrition during infancy
Table 2 Inter-correlations (Pearson’s r) between anthropometry, body composition and abdominal fat parameters in men (n = 36)
and women (n = 40)
Weight BMI Waist Hip Total fat mass (DEXA) VATa (MRI) SCATb (MRI)
Men
Weight 1
BMI 0.91 1
Waist 0.83 0.87 1
Hip 0.83 0.62 0.62 1
Total fat mass 0.82 0.84 0.84 0.72 1
VATa 0.55 0.59 0.68 0.55 0.68 1
SCATb 0.71 0.82 0.78 0.68 0.9 0.72 1
Women
Weight 1
BMI 0.96 1
Waist 0.81 0.82 1
Hip 0.83 0.88 0.76 1
Total fat mass 0.87 0.89 0.67 0.81 1
VATa 0.62 0.63 0.5 0.6 0.66 1
SCATb 0.84 0.89 0.71 0.77 0.93 0.63 1
P < 0.05 for all correlations
aVAT visceral adipose tissue
bSCAT subcutaneous adipose tissue
Table 3 Pearson’s correlation coefficients (P-values) between body fat parameters and metabolic outcomes by sex
Men (n = 36) Women (n = 40)
MetS HOMA-IR MetS HOMA-IR
Anthropometry Weight 0.32 (0.056) 0.43 (0.009) 0.27 (0.09) 0.18 (0.24)
BMI 0.45 (0.005) 0.52 (0.001) 0.31 (0.049) 0.22 (0.20)
Waist 0.26 (0.12) 0.50 (0.002) 0.17 (0.28) 0.15 (0.34)
Hip 0.26 (0.12) 0.34 (0.03) 0.26 (0.10) 0.19 (0.23)
DEXA Total fat mass 0.37 (0.03) 0.58 (0.0002) 0.30 (0.059) 0.15 (0.35)
MRI VATa 0.23 (0.20) 0.40 (0.01) 0.26 (0.12) 0.12 (0.46)
SCATb 0.50 (0.002) 0.66 (<0.0001) 0.28 (0.07) 0.18 (0.27)
Correlations with P-values < 0.05 are highlighted in bold
aVAT Visceral adipose tissue by MRI
bSCAT Subcutaneous adipose tissue by MRI
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or in utero [36, 37]. Our findings, suggest that preferential
accumulation of abdominal SCAT in black young adults
may have adverse consequences for insulin resistance and
metabolic syndrome traits. However, it is yet unclear why
abdominal SCAT might have greater adverse consequences
in black Africans than in white Europeans. Early life expo-
sures may play some role; Bto20 men had higher preva-
lence of early childhood stunting than women [38].
Limitations of our study include the modest sample size,
which could have limited the power to identify associa-
tions with VAT, however this is compensated by the use of
accurate and precise MRI imaging to quantify VAT and
SCAT. Our analysis was cross-sectional, therefore we can-
not exclude reverse-causality, i.e. possible effects of insulin
and glucose metabolism on abdominal fat. Our population
was young and the majority had healthy range BMI values;
it is possible that associations between abdominal fat dis-
tribution and metabolic traits are stronger in older popu-
lations and in those with long-standing overweight or
obesity. Although MRI assessment of SCAT and VAT has
been validated [39] and it is generally accepted as a refer-
ence method to quantify these adipose depots [40], the
fact that we quantified VAT and SCAT from only a single
slice may be a limitation in our study as it may not fully
capture the inter-individual variation in abdominal fat dis-
tribution [41]. However, we chose a standard MRI slice (at
the L4 vertebrae) and our sensitivity analysis (which quan-
tified VAT and SCAT at a lower single slice 36 mm lower,
approximately at L5) revealed essentially similar findings
(data not shown). We were unable to distinguish effects of
deep and superficial SCAT, as these sub-compartments
were almost completely co-linearly related to abdominal
SCAT in our sample. We were also unable to differentiate
between effects of abdominal SCAT and total fat mass, as
these compartments were also co-linearly related. We did
not adjust or stratify the analyses for other factors, such as
physical activity, diet, early life factors and social factors.
Future larger studies are needed to explore the potential
contributions of those factors to metabolic syndrome
traits in this population. We are not aware of other data
on VAT and abdominal SCAT in similar aged healthy
young adults; future studies are needed to confirm that
the abdominal fat distributions observed here are repre-
sentative of other black African populations.
Conclusion
In conclusion, in black South African young adults, SCAT
may be equally, or even more, relevant than VAT to
metabolic syndrome traits. The tendency for black indi-
viduals to accumulate SCAT rather than VAT is not ne-
cessarily beneficial to metabolic disease risks. Future
studies should explore the early life determinants and
current lifestyle correlates of abdominal fat distribution
in black populations.
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